Analysis of real-word mutations of lung cancer driver genes in five regions of China
Mengyao Sun(Second Military Medical University), Kewei Ma(Jilin University), Yinghui Xu(University of Utah), Xiumei Duan, Yutong Dong(Joslin Diabetes Center), Ye Guo(Jilin University), Peng Zhang(Tongji University), Xu Wang(Tulane University), Chao Sun(Second Hospital of Shandong University), Zhiguang Yang(Jilin University), Yunpeng Liu(Shenyang Institute of Automation), Guoguang Shao(First Hospital of Jilin University)
Cited by 7
Related Papers
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
|Nature Genetics|2014|1.1k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551